Cargando…
A new painkiller nanomedicine to bypass the blood-brain barrier and the use of morphine
The clinical use of endogenous neuropeptides has historically been limited due to pharmacokinetic issues, including plasma stability and blood-brain barrier permeability. In this study, we show that the rapidly metabolized Leu-enkephalin (LENK) neuropeptide may become pharmacologically efficient owi...
Autores principales: | Feng, Jiao, Lepetre-Mouelhi, Sinda, Gautier, Anne, Mura, Simona, Cailleau, Catherine, Coudore, François, Hamon, Michel, Couvreur, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374102/ https://www.ncbi.nlm.nih.gov/pubmed/30788432 http://dx.doi.org/10.1126/sciadv.aau5148 |
Ejemplares similares
-
Lipid-Conjugation of Endogenous Neuropeptides: Improved Biotherapy against Human Pancreatic Cancer
por: Gopalakrishnan, Gopakumar, et al.
Publicado: (2015) -
Assessment of Squalene-Adenosine Nanoparticles in Two Rodent Models of Cardiac Ischemia-Reperfusion
por: Brusini, Romain, et al.
Publicado: (2023) -
Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery
por: Sobot, Dunja, et al.
Publicado: (2017) -
Over-the-Counter Painkillers and Evolutionary Mismatch
por: Gallup, Andrew C.
Publicado: (2019) -
Synthesis of a deuterated probe for the confocal Raman microscopy imaging of squalenoyl nanomedicines
por: Buchy, Eric, et al.
Publicado: (2016)